Inoculums development for the production of monoclonal antibody against congenital adrenal hyperplasia(cah)

By now, the importance of inoculums development was well appreciated in bioprocessing. Inoculums development receives as much care and attention as the growth and product cycles. The status or “health” of the inoculums has a great deal to do with the success of the production cycle. In this project,...

Full description

Bibliographic Details
Main Author: Leong, Choon Wei
Format: Undergraduates Project Papers
Language:English
Published: 2010
Subjects:
Online Access:http://umpir.ump.edu.my/id/eprint/3191/
http://umpir.ump.edu.my/id/eprint/3191/
http://umpir.ump.edu.my/id/eprint/3191/1/CD5601_LEONG_CHOON_WEI.pdf
id ump-3191
recordtype eprints
spelling ump-31912015-03-03T07:59:56Z http://umpir.ump.edu.my/id/eprint/3191/ Inoculums development for the production of monoclonal antibody against congenital adrenal hyperplasia(cah) Leong, Choon Wei TP Chemical technology By now, the importance of inoculums development was well appreciated in bioprocessing. Inoculums development receives as much care and attention as the growth and product cycles. The status or “health” of the inoculums has a great deal to do with the success of the production cycle. In this project, inoculums development for the production of monoclonal antibody against Congenital Adrenal Hyperplasia (CAH) was studied. The scopes focused were the age of inoculums (passage number) and inoculums density at different growth phases. A hybridoma cell line (Hybridoma 192) was cultivated in batch mode with varying inoculums cell densities and growth phases using Dulbecco’s Modified Eagle Medium (DMEM). The maximum viable cell densities and the average specific MAb production rate (rp) were found to dependent on the inoculums cell density and the growth phases. Inoculums with low cell density at 5X104cells/ml and early log phase (t=28h) have the highest average specific MAb production rate but a low maximum viable cell density. Varying inoculums cell densites and growth phases did not affect the specific growth rate, maximum MAb titer and net production of MAb. Since the inoculums density in the range of 5x104 cells/ml to 5x105 cells/ml and growth phase do not affect the net production of MAb, it is wise to use high initial inoculums cell density at 5x105 cells/ml because the cell growth easily and faster compare low inoculums density. For the inoculums age, the average specific MAb production rate decreased when the passage number increased from PN (Passage Number) =9 to PN=30.Subculture exceeding critical passage number 9 was thus not recommended. 2010-11 Undergraduates Project Papers NonPeerReviewed application/pdf en http://umpir.ump.edu.my/id/eprint/3191/1/CD5601_LEONG_CHOON_WEI.pdf Leong, Choon Wei (2010) Inoculums development for the production of monoclonal antibody against congenital adrenal hyperplasia(cah). Faculty of Chemical & Natural Resources Engineering , Universiti Malaysia Pahang . http://iportal.ump.edu.my/lib/item?id=chamo:58166&theme=UMP2
repository_type Digital Repository
institution_category Local University
institution Universiti Malaysia Pahang
building UMP Institutional Repository
collection Online Access
language English
topic TP Chemical technology
spellingShingle TP Chemical technology
Leong, Choon Wei
Inoculums development for the production of monoclonal antibody against congenital adrenal hyperplasia(cah)
description By now, the importance of inoculums development was well appreciated in bioprocessing. Inoculums development receives as much care and attention as the growth and product cycles. The status or “health” of the inoculums has a great deal to do with the success of the production cycle. In this project, inoculums development for the production of monoclonal antibody against Congenital Adrenal Hyperplasia (CAH) was studied. The scopes focused were the age of inoculums (passage number) and inoculums density at different growth phases. A hybridoma cell line (Hybridoma 192) was cultivated in batch mode with varying inoculums cell densities and growth phases using Dulbecco’s Modified Eagle Medium (DMEM). The maximum viable cell densities and the average specific MAb production rate (rp) were found to dependent on the inoculums cell density and the growth phases. Inoculums with low cell density at 5X104cells/ml and early log phase (t=28h) have the highest average specific MAb production rate but a low maximum viable cell density. Varying inoculums cell densites and growth phases did not affect the specific growth rate, maximum MAb titer and net production of MAb. Since the inoculums density in the range of 5x104 cells/ml to 5x105 cells/ml and growth phase do not affect the net production of MAb, it is wise to use high initial inoculums cell density at 5x105 cells/ml because the cell growth easily and faster compare low inoculums density. For the inoculums age, the average specific MAb production rate decreased when the passage number increased from PN (Passage Number) =9 to PN=30.Subculture exceeding critical passage number 9 was thus not recommended.
format Undergraduates Project Papers
author Leong, Choon Wei
author_facet Leong, Choon Wei
author_sort Leong, Choon Wei
title Inoculums development for the production of monoclonal antibody against congenital adrenal hyperplasia(cah)
title_short Inoculums development for the production of monoclonal antibody against congenital adrenal hyperplasia(cah)
title_full Inoculums development for the production of monoclonal antibody against congenital adrenal hyperplasia(cah)
title_fullStr Inoculums development for the production of monoclonal antibody against congenital adrenal hyperplasia(cah)
title_full_unstemmed Inoculums development for the production of monoclonal antibody against congenital adrenal hyperplasia(cah)
title_sort inoculums development for the production of monoclonal antibody against congenital adrenal hyperplasia(cah)
publishDate 2010
url http://umpir.ump.edu.my/id/eprint/3191/
http://umpir.ump.edu.my/id/eprint/3191/
http://umpir.ump.edu.my/id/eprint/3191/1/CD5601_LEONG_CHOON_WEI.pdf
first_indexed 2023-09-18T21:57:18Z
last_indexed 2023-09-18T21:57:18Z
_version_ 1777414165182283776